A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma

Clinical trial NCT00476554 · TERMINATED

Trial details

NCT number: NCT00476554
Sponsor: Cyclacel Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma (CTCL)

Start date: 2007-04-01
Primary completion: 2012-03-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.